After 24 h treatment, TF from 0.22 to 2.0 μg/ml (0.4, 1.3, and 3.9 μM) obviously inhibited the A375 tumor growth, with inhibitory rates from 1.0 to 46.4%. The gene discussed is TF; the disease is neoplasm.